Zobrazeno 1 - 10
of 13 803
pro vyhledávání: '"HEREGULIN"'
Autor:
Monje, Paula V.1 (AUTHOR) pmonje@iu.edu, Bacallao, Ketty2 (AUTHOR), Aparicio, Gabriela I.1,3 (AUTHOR), Lalwani, Anil4 (AUTHOR)
Publikováno v:
Biological Procedures Online. 11/12/2021, Vol. 23 Issue 1, p1-14. 14p.
Autor:
Raluca-Ioana Stefan-van Staden, Oana-Raluca Musat, Damaris-Cristina Gheorghe, Ruxandra-Maria Ilie-Mihai, Catalina Cioates Negut, Paula Sfirloaga
Publikováno v:
Talanta Open, Vol 6, Iss , Pp 100151- (2022)
Microsensors based on the physical immobilization of oleamides (N-(pyridine-3-yl-methyl) oleamide, and N-(2-mercapto-1H-benzo[d]imidazole-5-yl) oleamide) on paste containing nanographene decorated with spheroidal Cu were proposed for the molecular re
Externí odkaz:
https://doaj.org/article/c238253403094445b4ed8d94c0739eb3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Chinese Journal of Ophthalmology & Otorhinolaryngology. 7/25/2024, Vol. 24 Issue 4, p298-302. 5p.
Autor:
Thomas M. Steele, Maria Malvina Tsamouri, Salma Siddiqui, Christopher A. Lucchesi, Demitria Vasilatis, Benjamin A. Mooso, Blythe P. Durbin-Johnson, Ai-Hong Ma, Nazila Hejazi, Mamta Parikh, Maria Mudryj, Chong-xian Pan, Paramita M. Ghosh
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Abstract Cisplatin-based combination chemotherapy is the foundation for treatment of advanced bladder cancer (BlCa), but many patients develop chemoresistance mediated by increased Akt and ERK phosphorylation. However, the mechanism by which cisplati
Externí odkaz:
https://doaj.org/article/e7fd4fc41429405c9cbe1caf0f8d8467
Autor:
Stefan-van Staden, Raluca-Ioana1,2 (AUTHOR) ralucavanstaden@gmail.com, Negut, Catalina Cioates1 (AUTHOR) negutcatalina79@gmail.com, Gheorghe, Sorin Sebastian2 (AUTHOR), Ciorîță, Alexandra3 (AUTHOR)
Publikováno v:
Analytical & Bioanalytical Chemistry. May2021, Vol. 413 Issue 13, p3487-3492. 6p.
Autor:
Hanna Huebner, Christian M. Kurbacher, Geoffrey Kuesters, Andreas D. Hartkopf, Michael P. Lux, Jens Huober, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Hans Tesch, Lothar Häberle, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Matthias Ruebner, Michael Untch, Peter A. Fasching, Wolfgang Janni, Tanja N. Fehm, Hans-Christian Kolberg, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Johannes Ettl
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Eligibility criteria are a critical part of clinical trials, as they define the patient population under investigation. Besides certain patient characteristics, clinical trials often include biomarker testing for eligibility. Howe
Externí odkaz:
https://doaj.org/article/3595f6bd2f1948ae89b5ca12ff495d0f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bogdanovich, Sasha, Jensen, Claus J., Fischer, M. Dominik, Hansen-Schwartz, Jacob, Javazon, Elisabeth H., Flake, Alan W., Edvinsson, Lars, Khurana, Tejvir S., Kunkel, Louis M.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2004 Sep . 101(38), 13856-13860.
Externí odkaz:
https://www.jstor.org/stable/3373298
Autor:
Yonesaka, Kimio1 yonesaka@med.kindai.ac.jp, Iwama, Eiji2, Hayashi, Hidetoshi1, Suzuki, Shinichiro1, Kato, Ryoji1, Watanabe, Satomi1, Takahama, Takayuki1, Tanizaki, Junko1, Tanaka, Kaoru1, Takeda, Masayuki1, Sakai, Kazuko3, Azuma, Koichi4, Chiba, Yasutaka5, Atagi, Shinji6, Nishio, Kazuto3, Okamoto, Isamu2, Nakagawa, Kazuhiko1
Publikováno v:
Scientific Reports. 12/20/2019, Vol. 9 Issue 1, p1-7. 7p.